Facial disease treatment device and control method thereof
By combining the electrical pulses and dilated airbags of facial disease treatment devices and combining facial feature data analysis, the problems of inaccurate control and single function in the prior art are solved, and the precise treatment of facial neuritis is achieved to adapt to the needs of different patients.
Patent Information
- Application Number
- CN202411218682.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-02
- Publication Date
- 2024-11-19
AI Technical Summary
The control adjustment of existing facial neuritis treatment devices is not comprehensive enough, resulting in inaccurate control and single function, making it difficult to adapt to actual needs.
A facial disease treatment device is designed, combining an electrical pulse generation controller, an electrode patch and an expansion airbag, connected through an electrical signal output cable and a connector, the electrode patch is placed on the acupoint outside the mouth, and the air pressure conduit is used to cooperate with a manual inflatable balloon. , The electrical pulse generation controller includes a power module, a CPU core module and a voltage pulse switch module. The electrical pulse intensity and frequency are adjusted through algorithms, and the facial feature data set is obtained and analyzed and the reference data set in the database is compared to the reference data set in the database to calculate the facial The characteristics conform to the index and dynamically adjust the control parameters.
Accurate control of the opposite neuritis is achieved, providing a combination of electrical and mechanical stimulation, adapting to the unique needs of different patients, and improving the accuracy and flexibility of treatment.
Smart Images

Figure CN118976196A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of therapeutic instruments, in particular to a facial disease therapeutic device and a control method thereof. Background Art
[0002] Facial neuritis is a disease characterized by motor dysfunction of facial expression muscles. It is a common and frequently occurring disease in clinic. It is not limited by age. It mainly occurs on one side, and some patients have bilateral disease at the same time. The general symptoms are crooked mouth and eyes. Patients often cannot even complete the most basic movements such as raising eyebrows, closing eyes, and puffing mouth. At present, the pathogenesis of the disease is still unclear. Most people believe that the occurrence of the disease is related to non-suppurative inflammation caused by viruses, which invade the facial nerve, causing spasm of the blood vessels that control the facial nerve in this area, and reduced blood supply, resulting in nerve edema caused by ischemia of the tissues around the facial nerve. Some patients have stenosis of the inner cavity due to poor development of the facial nerve canal, so that the facial nerve is compressed by edema under ischemia, and the nerve nutrition supply is impaired, resulting in nerve demyelination injury, and then the facial nerve loses control of the facial muscles. Although there are many causes of facial neuritis, most of the diseases can be cured, which are divided into acute phase, recovery phase and sequelae phase.
[0003] The parameters on which the control and adjustment of existing treatment devices for facial neuritis are based are not comprehensive, resulting in inaccurate control of the treatment devices. In addition, the existing treatment devices have the problem of single function and are difficult to adapt to actual needs. Summary of the invention
[0004] In view of the deficiencies in the prior art, the present invention provides a facial disease treatment device and a control method thereof, which solves the problems that the parameters based on which the control adjustment of the existing treatment device for facial neuritis is based are incomplete, resulting in inaccurate control of the treatment device, and that the existing treatment device has a single function and is difficult to adapt to actual needs.
[0005] To achieve the above objectives, the present invention is implemented through the following technical solutions: a facial disease treatment device, including an electric pulse generating controller, an electrode patch and an expansion airbag, the electric pulse generating controller is connected to a connector through an electrical signal output cable, the connector is connected to the expansion airbag, the surface of the expansion airbag is fixedly connected with electrode contacts and a silicone gasket supporting the expansion airbag; the connector is fixedly connected to two electrode patches, the electrode patches are used to be placed on extraoral acupuncture points, and the connector is connected to a manual inflation ball through an air pressure catheter.
[0006] Furthermore, the electric pulse generating controller includes a power supply module, a CPU core module and a voltage pulse switch module. The power supply module supplies power to the CPU core module in one way and supplies power to the voltage pulse switch module in another way, and then is respectively connected to the electrode patch and the electrode contact through an electrical signal output cable, and the voltage pulse switch module is controlled by the CPU core module program.
[0007] Furthermore, the power module includes a charging circuit, a low-power switch control circuit and a voltage conversion circuit, the charging circuit is connected to the low-power switch control circuit, and the low-power switch control circuit is connected to the voltage conversion circuit.
[0008] Furthermore, the CPU core module includes a CPU core chip, and the output end of the CPU core chip is respectively connected to the voltage pulse switch module, the TFT display and the buzzer.
[0009] Furthermore, the voltage pulse switch module includes a boost control circuit and a 6-way switch switching and pulse output circuit, and the 6-way switch switching and pulse output circuit is respectively connected to the electrode patch and the electrode contact through an electrical signal output cable.
[0010] Furthermore, the expansion balloon is an elastic ellipsoid.
[0011] A control method for a facial disease treatment device comprises the following steps: controlling the facial disease treatment device according to current facial disease treatment device control parameters, obtaining a facial feature data set of the facial disease treatment device under the control of the current facial disease treatment device control parameters, wherein the facial feature data set includes facial strength data and facial physicochemical data; obtaining a facial feature parameter data set stored in a database, wherein the facial feature parameter data set stored in the database includes facial strength parameter data and facial physicochemical parameter data; comparing and analyzing the facial feature data set with the facial feature parameter data set stored in the database to obtain a facial feature compliance index; comparing the facial feature compliance index with a compliance threshold stored in the database, if the facial feature compliance index is greater than the compliance threshold stored in the database, replacing the current facial disease treatment device control parameters, if the facial feature compliance index is less than or equal to the compliance threshold stored in the database, continuing to execute the current facial disease treatment device control parameters.
[0012] Furthermore, the facial feature data set is compared and analyzed with the facial feature parameter data set stored in the database to obtain the facial feature conformity index, including the following steps: comparing and analyzing the facial strength data with the facial strength parameter data to obtain the facial strength comparison coefficient; comparing and analyzing the facial physicochemical data with the facial physicochemical parameter data to obtain the facial physicochemical comparison coefficient; obtaining the facial symmetry deviation coefficient based on the current stimulation mode: obtaining the facial feature conformity index based on the facial strength comparison coefficient, the facial physicochemical comparison coefficient and the facial symmetry deviation coefficient.
[0013] Furthermore, the calculation formula of the facial feature conformity index is as follows:
[0014] MB=e G+F +H;
[0015] Where MB is the facial feature conformity index, G is the facial strength comparison coefficient, F is the facial physicochemical comparison coefficient, H is the facial symmetry deviation coefficient, and e is a natural constant.
[0016] Furthermore, the process of replacing the current facial disease treatment device control parameters is as follows: obtaining the difference between the facial feature compliance index and the compliance threshold stored in the database, comparing the difference with the matching differences corresponding to each group of alternative facial disease treatment device control parameters stored in the database, obtaining the alternative facial disease treatment device control parameters corresponding to the successfully matched matching differences, applying the alternative facial disease treatment device control parameters obtained by comparison to the facial disease treatment device, and continuing to stimulate the patient's face.
[0017] The present invention has the following beneficial effects:
[0018] (1) The facial disease treatment device can provide electrical stimulation and mechanical stimulation at the same time by combining electrical pulse stimulation with physical stimulation of an expansion airbag. The design of the electrode patch allows the electrical pulse to be accurately applied to the acupuncture points outside the mouth. The introduction of the CPU core module allows the voltage pulse switch module to be controlled according to the program to achieve precise adjustment of the intensity and frequency of the electrical pulse, thereby solving the problem that the parameters based on which the control and adjustment of existing treatment devices for facial neuritis are based are incomplete, resulting in inaccurate control of the treatment device, and that existing treatment devices have the problem of single function and are difficult to adapt to actual needs.
[0019] (2) The control method of the facial disease treatment device can adjust the control parameters of the facial disease treatment device to adapt to the unique treatment needs of each patient by acquiring and analyzing the facial feature data set and comparing it with the reference data set in the database. A data-based method is used to drive the control decision of the facial disease treatment device, and algorithms and calculation formulas (such as the calculation of the facial feature compliance index) are used to ensure the objectivity and accuracy of the control of the facial disease treatment device.
[0020] Of course, any product implementing the present invention does not necessarily need to achieve all of the advantages described above at the same time. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1 This is a schematic diagram of the structure of the facial disease treatment device of the present invention;
[0022] Figure 2 This is a schematic diagram of the structure of the facial disease treatment device of the present invention;
[0023] Figure 3 A circuit diagram of a power module of a facial disease treatment device according to the present invention;
[0024] Figure 4 A circuit diagram of a charging circuit of a facial disease treatment device according to the present invention;
[0025] Figure 5 A circuit diagram of a low-power switch control circuit of a facial disease treatment device according to the present invention;
[0026] Figure 6 A circuit diagram of a voltage conversion circuit of a facial disease treatment device according to the present invention;
[0027] Figure 7 This is a circuit diagram of the CPU core module of the facial disease treatment device of the present invention;
[0028] Figure 8 A circuit diagram of a voltage boost control circuit of a facial disease treatment device according to the present invention;
[0029] Fig. 9 A circuit for a 1-way pulse switch circuit of a facial disease treatment device of the present invention;
[0030] Fig.10 A circuit for a 2-way pulse switch circuit of a facial disease treatment device of the present invention;
[0031] Fig.11 The facial disease treatment device of the present invention has a circuit of a 3-way pulse switch circuit;
[0032] Fig.12 A circuit for a 4-way pulse switch circuit of a facial disease treatment device of the present invention;
[0033] Fig.13 A circuit for a 5-way pulse switch circuit of a facial disease treatment device of the present invention;
[0034] Fig.14 A circuit for a 6-way pulse switch circuit of a facial disease treatment device of the present invention;
[0035] Fig.15 This is a flow chart of a control method of the facial disease treatment device of the present invention;
[0036] Fig.16 The facial features of the control method of the facial disease treatment device of the present invention conform to the exponential function diagram. In the figure: 1, electric pulse generation controller; 2, electrode patch; 3, expansion air bag; 4, electric signal output cable; 5, electrode contact; 6, manual inflation ball; 7, air pressure catheter; 8, connector; 9, silicone gasket; 10, power module; 11, CPU core module; 12, voltage pulse switch module. DETAILED DESCRIPTION
[0037] The embodiment of the present application solves the problem that the parameters based on which the control adjustment of the existing treatment device for facial nerve paralysis is based are incomplete, resulting in inaccurate control of the treatment device, and the existing treatment device has the problem of single function and is difficult to adapt to actual needs through the facial disease treatment device and its control method.
[0038] See also Figure 1 The embodiment of the present invention provides a technical solution: a facial disease treatment device, including an electric pulse generating controller 1, an electrode patch 2 and an expansion airbag 3, the electric pulse generating controller 1 is connected to a connector 8 through an electric signal output cable 4, the connector 8 is connected to the expansion airbag 3, and the surface of the expansion airbag 3 is fixedly connected with an electrode contact 5; the connector 8 is fixedly connected to two electrode patches 2, the electrode patches 2 are used to be placed on extraoral acupuncture points, the connector 8 is connected to a manual inflation ball 6 through an air pressure catheter 7, and the expansion airbag 3 is an elastic ellipsoid.
[0039] The other end of the electric signal output cable 4 of the electric pulse generation controller 1 is connected to the electrode patch 2 and the electrode contact 5 on the expansion balloon 3 .
[0040] The electrode patch 2 is composed of a pair of positive and negative electrodes connected to the electric pulse generating controller 1 through an electrical signal output cable 4. The electrode patch 2 can be placed on any extraoral acupuncture point, such as Yangbai point, Sibai point, Sizhukong point, Yifeng point, Quanliao point, Dicang point, Yangbai point, etc.
[0041] The expansion balloon 3 is an elastic ellipsoid, and an electrode contact 5 connected to an electrical signal output cable 4 is provided on one side of the ellipsoid, and a silicone gasket 9 supporting the shaping of the balloon is attached to the other side opposite to the expansion balloon 3. The expansion balloon 3 is connected to a manual inflatable ball 6 through an air pressure catheter 7. The expansion balloon 3 can electrically stimulate the acupuncture points in the oral cavity. When in use, the expansion balloon 3 is placed in the patient's oral cavity, and electrical stimulation is performed at different periods. The expansion and contraction of the expansion balloon 3 combined with different waveforms and frequencies can make the facial muscles move actively and passively, and at the same time, electrical stimulation is performed flexibly to achieve the effect of adjusting the facial muscle groups. The current and stimulation methods of the acupuncture points in the mouth and outside the mouth make the acupuncture point stimulation more comprehensive.
[0042] During the acute phase of the patient, the expansion and contraction of the expansion airbag 3 can drive the facial muscles to perform passive movements, thereby improving the blood circulation at the root of the facial nerve branches, nourishing the nerves, and restoring muscle function; during the patient's recovery phase, the expansion and contraction of the expansion airbag 3 can enable the patient to complete a combination of active and passive movements of the facial muscles; during the patient's sequelae phase, the filled expansion airbag 3 fully stretches the facial muscles and soothes the muscles.
[0043] Compared with traditional acupuncture, the intraoral design can freely regulate the muscles and acupoints in the patient's mouth. External stimulation does not have passive movement, but the intraoral design can help patients do passive movement. At the same time, the acupoints for muscle stimulation are selected, and the positioning is more accurate. At the same time, it can be used in all stages of facial paralysis, with flexible function conversion, convenient operation, and more targeted.
[0044] Specifically, Figure 2 As shown, the electric pulse generating controller 1 includes a power supply module 10, a CPU core module 11 and a voltage pulse switch module 12. The power supply module 10 supplies power to the CPU core module 11 in one way and supplies power to the voltage pulse switch module 12 in another way, and then is respectively connected to the electrode patch 2 and the electrode contact 5 through the electrical signal output cable 4, and the voltage pulse switch module 12 is controlled by the CPU core module 11 program.
[0045] In this embodiment, the electric pulse generating controller 1 is composed of a power supply module 10, a CPU core module 11 and a voltage pulse switch module 12. The power supply module 10 supplies power to the CPU core module 11 in one way and supplies power to the voltage pulse switch module 12 in another way, and then is respectively connected to the electrode patch 2 and the electrode contact 5 through the electrical signal output cable 4, and the voltage pulse switch module 12 is controlled by the CPU core module 11 program.
[0046] Specifically, the power module 10 includes a charging circuit, a low-power switch control circuit and a voltage conversion circuit, the charging circuit is connected to the low-power switch control circuit, and the low-power switch control circuit is connected to the voltage conversion circuit, wherein the circuit diagram of the power module is as shown in Figure 3 As shown, the circuit diagram of the charging circuit is as follows Figure 4 As shown, the circuit diagram of the low power switch control circuit is as follows Figure 5 As shown, the circuit diagram of the voltage conversion circuit is as follows Figure 6 shown.
[0047] In this embodiment, the power module is composed of a charging circuit through a low-power switch control circuit and a voltage conversion circuit. The U1 module in the charging circuit controls the charging current through the R51 resistor to charge the battery P3; the voltage conversion circuit is composed of a boost circuit composed of components such as U3, L2, D2, R61, and R65. After the 3.7V voltage supplied by the charging circuit is increased to DC5V, a stable voltage is provided to the CPU core module 11 and the voltage pulse switch module 12, and the power supply is controlled by the low-power switch control circuit, that is, the 6th and 7th pins of the low-power switch control circuit are connected to the 3rd and 4th pins of the CPU core chip.
[0048] Specifically, the CPU core module 11 includes a CPU core chip, and the output end of the CPU core chip is connected to the voltage pulse switch module 12, the TFT display and the buzzer respectively. The circuit diagram of the CPU core module is as follows: Figure 7 shown.
[0049] In this embodiment, the output end of the CPU core chip of the CPU core module 11 is connected to the voltage pulse switch module 12, the TFT display, and the buzzer. The model of the CPU core chip is STC15W4K56S4. The voltage pulse switch module is connected to the I / O interface corresponding to the CPU core chip. The CPU core chip controls the voltage pulse switch module to output pulses of different forms. The CPU core chip drives the TFT display to display the switching frequency and corresponding information of the switch module and drives the buzzer circuit to emit a corresponding prompt tone.
[0050] Specifically, the voltage pulse switch module 12 includes a boost control circuit and a 6-way switch switching and pulse output circuit, and the 6-way switch switching and pulse output circuit is connected to the electrode patch 2 and the electrode contact 5 respectively through the electrical signal output cable 4. The circuit diagram of the boost control circuit is shown in FIG. Figure 8 As shown, the 6-way switch switching and pulse output circuit is as follows Figure 9-14 shown.
[0051] In this embodiment, the voltage pulse switch module is a bipolar output control circuit including a transistor, a load and a unipolar input bipolar output bipolar control circuit. It is composed of a boost control circuit and a 6-way switch switching and pulse output circuit connected in series. The 6-way switch switching and pulse output circuit is respectively connected to the electrode patch 2 and the electrode contact 5 through an electrical signal output cable 4.
[0052] The boost control circuit includes L1 inductor, D1 diode, C2 high-voltage capacitor and Q17 MOS tube. The 5V voltage output by the power management module charges the L1 inductor. After the PWM output by the CPU core chip controls the on and off of the Q17 MOS tube, the L1 inductor always works in the charge and discharge mode to form the required pulse voltage output to supply 6 groups of voltage pulse switch modules.
[0053] The 6-way switch switching and pulse output circuit is connected to the electrode patch and the silicone drum airbag through the connecting plug-in, and forms pulse electrical signals of different frequencies under different time instructions output at the CPU IO port. For example: when CH1+ receives a high level and CH1- receives a low level, Q5 and Q1 are turned on, Q9 is turned off, and POLE1 outputs positive pulse electricity; when CH2+ receives a low level and CH2- receives a high level, Q6 and Q2 are turned off, Q10 is turned on, and POLE2 outputs negative pulse electricity; thus POLE1 and POLE2 form a complete set of pulse electrical outputs.
[0054] Different time instructions are output from the IO port of the CPU to form pulse electrical signals of different frequencies. The BAT interface of the boost control circuit and the VDD TFT interface on the CPU core chip are connected to the VDD TTF interface on the voltage conversion circuit, the VDD MCU interface on the CPU core chip is connected to the VDD MCU on the voltage conversion circuit, the Boost Out interface of the boost control circuit is connected to the 6-way switch switching and pulse output circuit Boost Out, and the boost control circuit Boost-PWM is connected to the CPU core chip Boost-PWM.
[0055] When in use, the electric pulse generating controller 1 is installed with function keys connected to the CPU core chip. The strength of the pulse stimulation can be adjusted through the pulse enhancement key and pulse reduction key provided on the function keys, the output frequency of the pulse can be adjusted through the pulse mode selection key provided on the function keys, and the specific time limit of each pulse can be adjusted through the time control key provided on the function keys.
[0056] A control method for a facial disease treatment device, such as Fig.15As shown, the steps include: controlling the facial disease treatment device according to the current facial disease treatment device control parameters (the facial disease treatment device control parameters are different waveforms and frequency combinations of the control expansion airbag 3 and the currents of different electrode patches 2 stored in the database, and the current facial disease treatment device control parameters are determined by experts through analysis, so as to promote active and passive movements of facial muscles, and simultaneously perform electrical stimulation, the current and stimulation methods of the intraoral acupoints and the extraoral acupoints, so as to achieve the effect of adjusting the facial muscle groups), obtaining the facial disease treatment device under the control of the current facial disease treatment device control parameters. The facial feature data set includes facial strength data and facial physical and chemical data; obtaining a facial feature parameter data set stored in a database, the facial feature parameter data set stored in the database including facial strength parameter data and facial physical and chemical parameter data; comparing and analyzing the facial feature data set with the facial feature parameter data set stored in the database to obtain a facial feature compliance index; comparing the facial feature compliance index with a compliance threshold stored in the database, if the facial feature compliance index is greater than the compliance threshold stored in the database, replacing the current facial disease treatment device control parameters, if the facial feature compliance index is less than or equal to the compliance threshold stored in the database, continuing to execute the current facial disease treatment device control parameters.
[0057] The process of replacing the current control parameters of the facial disease treatment device is as follows: obtaining the difference between the facial feature compliance index and the compliance threshold stored in the database, comparing the difference with the matching differences corresponding to each group of alternative facial disease treatment device control parameters stored in the database, obtaining the alternative facial disease treatment device control parameters corresponding to the successfully matched matching differences, applying the compared alternative facial disease treatment device control parameters to the facial disease treatment device, and continuing to stimulate the patient's face.
[0058] The method of corresponding the matching difference and the control parameters of the alternative facial disease treatment device can be realized by establishing a database or table, which contains the matching difference between each group of control parameters and their corresponding values. Through a large number of experiments, the degree of deviation between the facial feature data and the standard parameter data under different control parameter combinations (such as different waveforms, frequencies, currents, etc.) is recorded, and these data are stored to establish a database containing control parameters and corresponding matching differences. Contains the following fields: control parameter ID, which uniquely identifies each group of alternative control parameters; control expansion balloon waveform, which stores the expansion balloon waveform under this group of control parameters; control expansion balloon frequency, which stores the expansion balloon frequency under this group of control parameters; electrode patch current, which stores the electrode patch current under this group of control parameters; matching difference: stores the matching difference corresponding to this group of control parameters.
[0059] The control parameters of the facial disease treatment device include the output frequency of the pulse, the specific duration of each pulse and the current size.
[0060] The control parameters of the facial disease treatment device can be gradually adjusted and optimized according to real-time feedback to ensure that each adjustment can avoid the discomfort and risks caused by large adjustments. Through gradual adjustment, the treatment process is more gentle and controllable, and the patient's comfort and acceptance are improved. By comparing the facial feature compliance index with the compliance threshold stored in the database, and using the difference to compare with the matching difference corresponding to each group of alternative parameters, the control parameters of the facial disease treatment device that best suits the current patient can be found. The data-driven approach can ensure that each parameter adjustment is based on scientific and objective data analysis, thereby improving the accuracy and pertinence of the treatment effect. The current control parameters of the facial disease treatment device are determined based on expert analysis. By combining the parameter data in the database with the real-time facial feature data for comparison and analysis, expert experience and actual data can be comprehensively considered, and the clinical experience of experts and historical data stored in the database can be fully utilized to improve the scientificity and reliability of the control of the facial disease treatment device.
[0061] The facial strength data include facial muscle strength, eye closure force and masseter strength, and the facial physicochemical data include facial muscle potential and facial blood flow. Facial muscle strength is obtained using a dynamometer (such as a handheld dynamometer or an electromyographic stimulation dynamometer). The dynamometer is placed on different muscle groups on the face to measure the maximum contraction force of the muscle by applying external force or electromyographic stimulation. Eye closure force is obtained using an eye closure force meter or a small spring dynamometer to measure the force generated by the eyelid muscles when the patient closes his eyes at maximum force and record the eyelid closure force value. Masseter strength is obtained using a masseter force meter (such as a bite dynamometer). The patient bites the meter and the instrument records the maximum bite force. The instrument is usually placed between the upper and lower teeth to measure the strength of the masseter muscles. Facial muscle potential is obtained using a surface electromyography (sEMG) device. The sEMG electrodes are attached to the surface of the facial muscles to measure the muscle potential by recording the electrical activity generated when the muscles contract. It is used to evaluate the function and health of the facial muscles. Facial blood flow is measured using laser Doppler flowmetry or thermal imaging, which measures the velocity and amount of blood flowing beneath the skin by illuminating the facial skin with laser light and detecting the frequency shift of the reflected light.
[0062] The facial strength parameter data include facial muscle strength, eye closing force and masseter strength, and the facial physical and chemical parameter data include facial muscle potential and facial blood flow. Both the facial strength parameter data and facial physical and chemical parameter data are obtained based on the data of healthy individuals, measured using corresponding instruments and equipment, and the collected data are filtered, denoised and calibrated to ensure data quality. The processed data are compared with the benchmark value (such as the average value of healthy individuals or historical data), and normalized or standardized to obtain the parameter value.
[0063] In this embodiment, the current stimulation method includes controlling different waveforms and frequency combinations of the expansion balloon and electrode patches, as well as the electric current of the acupuncture points inside and outside the mouth, with the purpose of promoting active and passive movement of the facial muscles, while performing electrical stimulation and adjusting the facial muscle groups. The facial feature data sets obtained include facial strength data and facial physical and chemical data.
[0064] Obtain a facial feature parameter data set stored in a database, which includes facial strength parameter data and facial physical and chemical parameter data, for comparative analysis. Obtain a facial feature compliance index through comparative analysis. If the compliance index is greater than the compliance threshold stored in the database, change the current stimulation method; if the compliance index is less than or equal to the threshold, continue to execute the current stimulation method.
[0065] Real-time monitoring of changes in facial muscles and physical and chemical indicators ensures the accuracy and real-time nature of facial feature data, which helps to adjust the stimulation method in a timely manner. The facial feature parameter data set stored in the database provides a standardized reference data set for easy comparison and analysis. By comparing and analyzing the impact of the current stimulation method on facial features, the effect can be quantified to clarify whether the current stimulation method is effective. The threshold value is set to determine whether the current stimulation method needs to be adjusted, providing an automated decision-making mechanism to dynamically adjust the stimulation method based on real-time data and standard thresholds to ensure continuous optimization of the stimulation effect.
[0066] Specifically, the facial feature data set is compared and analyzed with the facial feature parameter data set stored in the database to obtain the facial feature matching index, which includes the following steps: the facial strength data is compared and analyzed with the facial strength parameter data to obtain the facial strength comparison coefficient.
[0067] The calculation formula of the facial strength comparison coefficient is as follows (before calculation, all parameters are processed as scalars and units are removed):
[0068]
[0069] Where G is the facial strength comparison coefficient, LR is the facial muscle strength, LB is the eye closing force, LY is the masseter muscle strength, LR1 is the facial parameter muscle strength, LB1 is the eye parameter closing force, LY1 is the parameter masseter muscle strength, and e is a natural constant.
[0070] Before calculation, all parameters are unified into unitless scalars to ensure that different types of data can be calculated in the same formula. After removing the units, the data can be processed uniformly to avoid calculation errors caused by different units. The sum of the differences in facial muscle strength and eye closure force is calculated, and then the difference is amplified by the power of the natural constant e. By using the natural constant for exponential operation, the difference can be significantly amplified, highlighting the changes in strength under different stimulation methods. In this way, small but important changes can be captured more sensitively, allowing the device to respond more significantly to larger deviations. Calculate the relative change of masseter muscle strength and take its logarithm to smooth the change value. Use logarithmic function to process relative change, which can compress a large range of changes into a relatively small range, avoiding excessive or small values from affecting the overall comparison coefficient. The relative error of masseter muscle strength can more intuitively reflect the degree of change in masseter muscle strength.
[0071] By monitoring the difference between facial muscle strength and standard values in real time, the treatment device can dynamically adjust the output, such as the intensity or mode of electrical stimulation, according to the value of the facial strength comparison coefficient, thereby ensuring that the device operates at optimal efficiency. Exponential and logarithmic functions are used to enhance or suppress certain feedbacks, making the device more sensitive to changes in facial muscle status. Strong feedback is provided for large deviations, while subtle adjustments can be made for subtle changes to ensure that the device output accurately matches the actual situation. Calculating the facial strength comparison coefficient enables the device to respond instantly to any changes in facial muscles, providing continuous, data-based control guidance for the device, which is critical to maintaining device performance within the predetermined operating range.
[0072] The facial physicochemical data are compared and analyzed with the facial physicochemical parameter data to obtain the facial physicochemical comparison coefficient.
[0073] The calculation formula of the facial physicochemical comparison coefficient is as follows (before calculation, all parameters are processed as scalar quantities and the units are removed):
[0074]
[0075] Wherein, MY is the facial muscle potential, LC is the facial blood flow, MY1 is the facial muscle parameter potential, and LC1 is the facial parameter blood flow.
[0076] Table 1 Data on the variation of facial physicochemical comparison coefficient with the variation of facial muscle potential
[0077]
[0078]
[0079] As can be seen from the table, as MY (facial muscle potential) increases, the F value gradually increases, indicating an increase in deviation from the reference value. This calculation method allows us to quantify the degree to which changes in facial muscle potential affect the overall facial physiochemical characteristics. When LC (facial blood flow) remains constant, changes in MY completely determine the size of F, which emphasizes the importance of facial muscle potential in assessing the physiological state of the face.
[0080] This formula calculates the deviation of facial muscle potential and facial blood flow from the reference value, and uses the Euclidean distance to quantify the degree of deviation of these two key parameters. This deviation measurement method can provide a clear quantitative indicator for device control. The measurement of facial muscle potential can provide immediate feedback, indicating changes in muscle activity, while blood flow can provide information on tissue response over a longer time scale. In terms of device control, the comprehensive analysis of these measurements can help adjust the device output, such as adjusting the intensity or mode of electrical stimulation to optimize the treatment effect and avoid overstimulation. Using this comprehensive comparison coefficient can more accurately control the output of the device, ensuring that each application is based on real-time physiological data, making device adjustments more precise.
[0081] The facial strength comparison coefficient and the facial physicochemical comparison coefficient are processed to obtain the facial feature conformity index, and the facial strength comparison coefficient and the facial physicochemical comparison coefficient are processed to obtain the facial feature conformity index, which includes the following steps: obtaining the facial symmetry deviation coefficient based on the current stimulation mode; obtaining the facial feature conformity index based on the facial strength comparison coefficient, the facial physicochemical comparison coefficient and the facial symmetry deviation coefficient. The facial symmetry deviation coefficient is obtained by using a high-resolution camera to capture an image of the patient's face, and then analyzing the left-right symmetry of the face through image processing software. The symmetry analysis can be performed by comparing the position differences of key points on both sides of the face (such as the corners of the eyes, the corners of the mouth, etc.).
[0082] The calculation formula of facial feature conformity index is as follows:
[0083] MB=e G+F +H;
[0084] Where MB is the facial feature conformity index, G is the facial strength comparison coefficient, F is the facial physicochemical comparison coefficient, H is the facial symmetry deviation coefficient, and e is a natural constant.
[0085] Table 2 Facial feature compliance index calculation data
[0086] serial number G F H MB 1 0.1 0.1 0.5 1.721 2 0.3 0.2 1.0 2.649 3 0.5 0.3 1.5 3.726 4 0.7 0.4 2.0 5.004 5 0.9 0.5 2.5 6.555
[0087] It can be observed from the table that as the sum of G and F increases, the MB value increases exponentially, indicating that the facial features deviate more and more from the reference value, which means that the facial condition may be less and less ideal. Fig.16 As shown, this pattern of change reflects the exponential growth property in the MB formula, while the addition of H (facial symmetry deviation coefficient) further increases the value of MB, which emphasizes the importance of facial symmetry in the overall assessment.
[0088] In this embodiment, the calculation of the facial feature conformity index MB involves the facial strength comparison coefficient G, the facial physicochemical comparison coefficient F, and the facial symmetry deviation coefficient H. This calculation method provides a method for comprehensively evaluating facial features and feedback control for the facial disease treatment device. By combining facial strength, physicochemical characteristics, and symmetry deviation, the index provides a method for the device to comprehensively evaluate the facial state, which helps the device to more accurately adjust its control strategy to cope with complex facial conditions.
[0089] An electronic device comprises: a processor and a memory, wherein computer program instructions are stored in the memory, and when the computer program instructions are executed by the processor, the processor executes the facial disease treatment device as described above.
[0090] A computer-readable storage medium is used to store a program, and when the program is executed by a processor, the facial disease treatment device as described above is implemented.
[0091] Those skilled in the art will appreciate that embodiments of the present invention may be provided as methods, systems, or computer program products. Therefore, the present invention may take the form of a complete hardware embodiment, a complete software embodiment, or an embodiment combining software and hardware. Moreover, the present invention may take the form of a computer program product implemented on one or more computer-usable storage media (including but not limited to disk storage, CD-ROM, optical storage, etc.) containing computer-usable program code.
[0092] The present invention is described with reference to flowcharts and / or block diagrams of systems, devices (systems), and computer program products according to embodiments of the present invention. It should be understood that each process and / or block in the flowchart and / or block diagram, as well as the combination of processes and / or blocks in the flowchart and / or block diagram, can be implemented by computer program instructions. These computer program instructions can be provided to a processor of a general-purpose computer, a special-purpose computer, an embedded processor, or other programmable data processing device to produce a machine, so that the instructions executed by the processor of the computer or other programmable data processing device generate instructions for implementing the processes in the flowchart and / or block diagram. Figure 1 A process or multiple processes and / or boxes Figure 1 A device that provides the functions specified in a block or multiple blocks.
[0093] These computer program instructions may also be stored in a computer-readable memory capable of directing a computer or other programmable data processing device to operate in a specific manner, so that the instructions stored in the computer-readable memory produce an article of manufacture comprising an instruction device, which implements the process Figure 1 A process or multiple processes and / or boxes Figure 1 A function specified in one or more boxes.
[0094] These computer program instructions can also be loaded onto a computer or other programmable data processing device so that a series of operating steps are executed on the computer or other programmable device to produce a computer-implemented process, thereby providing instructions for implementing the process. Figure 1 A process or multiple processes and / or boxes Figure 1 The steps for the functions specified in one or more boxes.
[0095] Although the preferred embodiments of the present invention have been described, those skilled in the art may make other changes and modifications to these embodiments once they have learned the basic creative concept. Therefore, the appended claims are intended to be interpreted as including the preferred embodiments and all changes and modifications that fall within the scope of the present invention.
[0096] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.
Claims
1. A facial disease treatment device, It is characterized in that The device comprises an electric pulse generating controller (1), an electrode patch (2) and an expansion airbag (3), wherein the electric pulse generating controller (1) is connected to a connector (8) via an electric signal output cable (4), the connector (8) is connected to the expansion airbag (3), and the surface of the expansion airbag (3) is fixedly connected with an electrode contact (5) and a silicone gasket (9) supporting the expansion airbag (3); The connector (8) is fixedly connected to two electrode patches (2), and the electrode patches (2) are used to be placed on extraoral acupuncture points. The connector (8) is connected to a manual inflation ball (6) via an air pressure tube (7).
2. The facial disease treatment device according to claim 1, Features: The electric pulse generation controller (1) comprises a power supply module (10), a CPU core module (11) and a voltage pulse switch module (12); the power supply module (10) supplies power to the CPU core module (11) through one path, supplies power to the voltage pulse switch module (12) through another path, and then respectively connects to the electrode patch (2) and the electrode contact (5) through an electric signal output cable (4); and the voltage pulse switch module (12) is controlled by a program of the CPU core module (11).
3. The facial disease treatment device according to claim 2, Features: The power supply module (10) comprises a charging circuit, a low-power switch control circuit and a voltage conversion circuit, wherein the charging circuit is connected to the low-power switch control circuit, and the low-power switch control circuit is connected to the voltage conversion circuit.
4. The facial disease treatment device according to claim 2, Features: The CPU core module (11) comprises a CPU core chip, and the output end of the CPU core chip is respectively connected to a voltage pulse switch module (12), a TFT display and a buzzer.
5. The facial disease treatment device according to claim 2, Features: The voltage pulse switch module (12) comprises a boost control circuit and a 6-way switch switching and pulse output circuit, and the 6-way switch switching and pulse output circuit is respectively connected to the electrode patch (2) and the electrode contact (5) via an electrical signal output cable (4).
6. The facial disease treatment device according to claim 1, Features: The expansion balloon (3) is an elastic ellipsoid.
7. A control method for a facial disease treatment device, It is characterized in that The facial disease treatment device as claimed in any one of claims 1 to 6 comprises the following steps: Controlling the facial disease treatment device according to the current facial disease treatment device control parameters, and obtaining a facial feature data set of the facial disease treatment device under the control of the current facial disease treatment device control parameters, wherein the facial feature data set includes facial strength data and facial physical and chemical data; Acquire a facial feature parameter data set stored in a database, wherein the facial feature parameter data set stored in the database includes facial strength parameter data and facial physical and chemical parameter data; Compare and analyze the facial feature data set with the facial feature parameter data set stored in the database to obtain the facial feature matching index; The facial feature conformity index is compared with the conformity threshold stored in the database. If the facial feature conformity index is greater than the conformity threshold stored in the database, the current facial disease treatment device control parameters are replaced. If the facial feature conformity index is less than or equal to the conformity threshold stored in the database, the current facial disease treatment device control parameters continue to be executed.
8. The control method of the facial disease treatment device according to claim 7, It is characterized in that The facial feature dataset is compared and analyzed with the facial feature parameter dataset stored in the database to obtain the facial feature matching index, including the following steps: Compare and analyze the facial strength data with the facial strength parameter data to obtain the facial strength comparison coefficient; Compare and analyze the facial physicochemical data with the facial physicochemical parameter data to obtain the facial physicochemical comparison coefficient; Get the facial symmetry deviation coefficient based on the current stimulus mode: The facial feature conformity index was obtained based on the facial strength comparison coefficient, facial physicochemical comparison coefficient and facial symmetry deviation coefficient.
9. The control method of the facial disease treatment device according to claim 8, It is characterized in that The calculation formula of the facial feature conformity index is as follows: UK = e G+F +H; Where MB is the facial feature conformity index, G is the facial strength comparison coefficient, F is the facial physicochemical comparison coefficient, H is the facial symmetry deviation coefficient, and e is a natural constant.
10. The control method of the facial disease treatment device according to claim 9, It is characterized in that The process of replacing the current facial disease treatment device control parameters is as follows: obtaining the difference between the facial feature compliance index and the compliance threshold stored in the database, comparing the difference with the matching differences corresponding to each group of alternative facial disease treatment device control parameters stored in the database, obtaining the alternative facial disease treatment device control parameters corresponding to the successfully matched matching differences, applying the alternative facial disease treatment device control parameters obtained by comparison to the facial disease treatment device, and continuing to stimulate the patient's face.
